Neko Health, a company specializing in artificial intelligence-based body scanning services, has raised a staggering $700 million to further expand its operations in the United States. This significant investment marks a major milestone for Neko Health as it plans to establish a new clinic in New York to cater to an expanding customer base.
The AI body scan service, which combines medical imaging, blood tests, proprietary sensors, and clinician review, is designed to provide a comprehensive preventive screening experience for individuals looking to maintain their overall health. By leveraging AI technology, Neko Health aims to reduce healthcare costs, increase efficiency, and enhance patient outcomes while minimizing unnecessary procedures.
The Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. The funding will enable Neko Health to further develop its services, expand its reach in the US market, and establish strategic partnerships with medical professionals and organizations. With this investment, Neko Health is poised to revolutionize the way healthcare is delivered and experience a significant growth trajectory.